Back to Browse Journals » Vascular Health and Risk Management » Volume 11

Vascular Health and Risk Management


Archive: Volume 11, 2015

Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?

van de Hoef TP, Meuwissen M, Piek JJ

Vascular Health and Risk Management 2015, 11:613-622

Published Date: 3 December 2015

Personalized medicine and stroke prevention: where are we?

Kim J, Thrift AG, Nelson MR, Bladin CF, Cadilhac DA

Vascular Health and Risk Management 2015, 11:601-611

Published Date: 2 December 2015

Preseason preparation training and endothelial function in elite professional soccer players

Androulakis NE, Koundourakis NE, Nioti E, Spatharaki P, Hatzisymeon D, Miminas I, Alexandrakis MG

Vascular Health and Risk Management 2015, 11:595-599

Published Date: 26 November 2015

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy

Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D

Vascular Health and Risk Management 2015, 11:591-594

Published Date: 24 November 2015

Managing atrial fibrillation in the very elderly patient: challenges and solutions

Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A

Vascular Health and Risk Management 2015, 11:555-562

Published Date: 27 October 2015

Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study

Bosevski M, Stojanovska L

Vascular Health and Risk Management 2015, 11:549-553

Published Date: 16 October 2015

A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis

Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M

Vascular Health and Risk Management 2015, 11:541-547

Published Date: 18 September 2015

The MGuard coronary stent: safety, efficacy, and clinical utility

Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A

Vascular Health and Risk Management 2015, 11:533-539

Published Date: 18 September 2015

LDL electronegativity index: a potential novel index for predicting cardiovascular disease

Ivanova EA, Bobryshev YV, Orekhov AN

Vascular Health and Risk Management 2015, 11:525-532

Published Date: 28 August 2015

Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke

Helvig E, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2015, 11:507-510

Published Date: 3 September 2015

New developments in atherosclerosis: clinical potential of PCSK9 inhibition

Giunzioni I, Tavori H

Vascular Health and Risk Management 2015, 11:493-501

Published Date: 24 August 2015

Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia

Siviero-Miachon AA, Spinola-Castro AM, Lee ML, Monteiro CM, Carvalho AC, Calixto AR, Geloneze B, Guerra-Junior G

Vascular Health and Risk Management 2015, 11:479-488

Published Date: 18 August 2015

Prevention of venous thromboembolism in patients undergoing bariatric surgery

Bartlett MA, Mauck KF, Daniels PR

Vascular Health and Risk Management 2015, 11:461-477

Published Date: 17 August 2015

Assessing the risk of recurrent venous thromboembolism – a practical approach

Fahrni J, Husmann M, Gretener SB, Keo HH

Vascular Health and Risk Management 2015, 11:451-459

Published Date: 17 August 2015

Secondary stroke prevention: challenges and solutions

Esenwa C, Gutierrez J

Vascular Health and Risk Management 2015, 11:437-450

Published Date: 7 August 2015

Sex differences in predictors of ischemic stroke: current perspectives

Samai AA, Martin-Schild S

Vascular Health and Risk Management 2015, 11:427-436

Published Date: 27 July 2015

Preeclampsia: long-term consequences for vascular health

Amaral LM, Cunningham Jr MW, Cornelius DC, LaMarca B

Vascular Health and Risk Management 2015, 11:403-415

Published Date: 15 July 2015

Feasibility and safety of rehabilitation after venous thromboembolism

Noack F, Schmidt B, Amoury M, Stoevesandt D, Gielen S, Pflaumbaum B, Girschick C, Völler H, Schlitt A

Vascular Health and Risk Management 2015, 11:397-401

Published Date: 13 July 2015

Preoperative optimization of the vascular surgery patient

Zhan HT, Purcell ST, Bush RL

Vascular Health and Risk Management 2015, 11:379-385

Published Date: 1 July 2015

Role of diclofenac in the prevention of postpericardiotomy syndrome after cardiac surgery

Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Alp V, Beyazit U

Vascular Health and Risk Management 2015, 11:373-378

Published Date: 30 June 2015

Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study

Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B

Vascular Health and Risk Management 2015, 11:361-371

Published Date: 29 June 2015

Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA

Vascular Health and Risk Management 2015, 11:353-359

Published Date: 29 June 2015

Lipidomics in vascular health: current perspectives

Kolovou G, Kolovou V, Mavrogeni S

Vascular Health and Risk Management 2015, 11:333-342

Published Date: 12 June 2015

Blood pressure control to prevent decline in cognition after stroke

Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B

Vascular Health and Risk Management 2015, 11:311-316

Published Date: 9 June 2015

Epoprostenol sodium for treatment of pulmonary arterial hypertension

Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H

Vascular Health and Risk Management 2015, 11:265-270

Published Date: 14 May 2015

Lipid-modifying therapy in the elderly

Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, d'Emden M

Vascular Health and Risk Management 2015, 11:251-263

Published Date: 14 May 2015

Alogliptin benzoate for management of type 2 diabetes

Saisho Y

Vascular Health and Risk Management 2015, 11:229-243

Published Date: 10 April 2015

Breast cancer therapy and cardiovascular risk: focus on trastuzumab

Sandoo A, Kitas GD, Carmichael AR

Vascular Health and Risk Management 2015, 11:223-228

Published Date: 7 April 2015

Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits

Vokrri L, Qavdarbasha A, Rudari H, Ahmetaj H, Manxhuka-Kërliu S, Hyseni N, Porcu P, Cinquin P, Sessa C

Vascular Health and Risk Management 2015, 11:211-217

Published Date: 27 March 2015

Virtual reality simulation for the optimization of endovascular procedures: current perspectives

Rudarakanchana N, Van Herzeele I, Desender L, Cheshire NJW

Vascular Health and Risk Management 2015, 11:195-202

Published Date: 10 March 2015

Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR

Vascular Health and Risk Management 2015, 11:185-193

Published Date: 3 March 2015

Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms

Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC

Vascular Health and Risk Management 2015, 11:173-183

Published Date: 27 February 2015

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O’Neill EA, Mitchel YB

Vascular Health and Risk Management 2015, 11:165-172

Published Date: 24 February 2015

Strokes in young adults: epidemiology and prevention

Smajlović D

Vascular Health and Risk Management 2015, 11:157-164

Published Date: 24 February 2015

Platelet function tests: a comparative review

Paniccia R, Priora R, Alessandrello Liotta A, Abbate R

Vascular Health and Risk Management 2015, 11:133-148

Published Date: 18 February 2015

The role of factor Xa inhibitors in venous thromboembolism treatment

Cabral KP, Ansell JE

Vascular Health and Risk Management 2015, 11:117-123

Published Date: 30 January 2015

Prevention of stent thrombosis: challenges and solutions

Reejhsinghani R, Lotfi AS

Vascular Health and Risk Management 2015, 11:93-106

Published Date: 27 January 2015

Scaffolds in vascular regeneration: current status

Thottappillil N, Nair PD

Vascular Health and Risk Management 2015, 11:79-91

Published Date: 19 January 2015

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A

Vascular Health and Risk Management 2015, 11:71-78

Published Date: 21 January 2015

Adiponectin as a potential biomarker of vascular disease

Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z

Vascular Health and Risk Management 2015, 11:55-70

Published Date: 16 January 2015

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus

Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA

Vascular Health and Risk Management 2015, 11:35-48

Published Date: 6 January 2015

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE

Vascular Health and Risk Management 2015, 11:1-8

Published Date: 17 December 2014